Moreover, the Kaplan–Meier curve also confirmed that AML patients with increased expression of IFIT2/3/5 suffered shorter overall survival compared with patients with lower IFIT2/3/5 expression (Fig. 3B). This evidence concerns the gene IFIT2 and acute myeloid leukemia.